ArticleJournal of inflammation research2022

NLRP3 Inflammasome May Be a Biomarker for Risk Stratification in Patients with Acute Coronary Syndrome.

De-Gang Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.